149 related articles for article (PubMed ID: 27648138)
1. A human apolipoprotein E mimetic peptide reduces atherosclerosis in aged apolipoprotein E null mice.
Xu Y; Liu H; Liu M; Li F; Liu L; Du F; Fan D; Yu H
Am J Transl Res; 2016; 8(8):3482-92. PubMed ID: 27648138
[TBL] [Abstract][Full Text] [Related]
2. Reverse D4F, an apolipoprotein-AI mimetic peptide, inhibits atherosclerosis in ApoE-null mice.
Qin S; Kamanna VS; Lai JH; Liu T; Ganji SH; Zhang L; Bachovchin WW; Kashyap ML
J Cardiovasc Pharmacol Ther; 2012 Sep; 17(3):334-43. PubMed ID: 22308547
[TBL] [Abstract][Full Text] [Related]
3. Dietary alpha-lipoic acid supplementation inhibits atherosclerotic lesion development in apolipoprotein E-deficient and apolipoprotein E/low-density lipoprotein receptor-deficient mice.
Zhang WJ; Bird KE; McMillen TS; LeBoeuf RC; Hagen TM; Frei B
Circulation; 2008 Jan; 117(3):421-8. PubMed ID: 18158360
[TBL] [Abstract][Full Text] [Related]
4. Hepatic overexpression of methionine sulfoxide reductase A reduces atherosclerosis in apolipoprotein E-deficient mice.
Xu YY; Du F; Meng B; Xie GH; Cao J; Fan D; Yu H
J Lipid Res; 2015 Oct; 56(10):1891-900. PubMed ID: 26318157
[TBL] [Abstract][Full Text] [Related]
5. PEP-1-MsrA ameliorates inflammation and reduces atherosclerosis in apolipoprotein E deficient mice.
Wu Y; Xie G; Xu Y; Ma L; Tong C; Fan D; Du F; Yu H
J Transl Med; 2015 Sep; 13():316. PubMed ID: 26410585
[TBL] [Abstract][Full Text] [Related]
6. SOAT1 deficiency attenuates atherosclerosis by regulating inflammation and cholesterol transportation via HO-1 pathway.
Wu N; Li RQ; Li L
Biochem Biophys Res Commun; 2018 Jun; 501(2):343-350. PubMed ID: 29567472
[TBL] [Abstract][Full Text] [Related]
7. Human apolipoprotein AI mimetic peptides for the treatment of atherosclerosis.
Navab M; Anantharamaiah GM; Reddy ST; Van Lenten BJ; Hough G; Wagner A; Nakamura K; Garber DW; Datta G; Segrest JP; Hama S; Fogelman AM
Curr Opin Investig Drugs; 2003 Sep; 4(9):1100-4. PubMed ID: 14582455
[TBL] [Abstract][Full Text] [Related]
8. Two apolipoprotein E mimetic peptides with similar cholesterol reducing properties exhibit differential atheroprotective effects in LDL-R null mice.
Handattu SP; Nayyar G; Garber DW; Palgunachari MN; Monroe CE; Keenum TD; Mishra VK; Datta G; Anantharamaiah GM
Atherosclerosis; 2013 Mar; 227(1):58-64. PubMed ID: 23159231
[TBL] [Abstract][Full Text] [Related]
9. Effect of macrophage-derived apolipoprotein E on hyperlipidemia and atherosclerosis of LDLR-deficient mice.
Shi W; Wang X; Wong J; Hedrick CC; Wong H; Castellani LW; Lusis AJ
Biochem Biophys Res Commun; 2004 Apr; 317(1):223-9. PubMed ID: 15047172
[TBL] [Abstract][Full Text] [Related]
10. Hepatic expression of apolipoprotein E inhibits progression of atherosclerosis without reducing cholesterol levels in LDL receptor-deficient mice.
Tsukamoto K; Tangirala RK; Chun S; Usher D; Puré E; Rader DJ
Mol Ther; 2000 Feb; 1(2):189-94. PubMed ID: 10933930
[TBL] [Abstract][Full Text] [Related]
11. Isoliquiritigenin Attenuates Atherogenesis in Apolipoprotein E-Deficient Mice.
Du F; Gesang Q; Cao J; Qian M; Ma L; Wu D; Yu H
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27869741
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-27 Prevents Atherosclerosis by Suppressing Lipoprotein Lipase-Induced Lipid Accumulation and Inflammatory Response in Apolipoprotein E Knockout Mice.
Xie W; Li L; Zhang M; Cheng HP; Gong D; Lv YC; Yao F; He PP; Ouyang XP; Lan G; Liu D; Zhao ZW; Tan YL; Zheng XL; Yin WD; Tang CK
PLoS One; 2016; 11(6):e0157085. PubMed ID: 27257686
[TBL] [Abstract][Full Text] [Related]
13. New role of PCSK9 in atherosclerotic inflammation promotion involving the TLR4/NF-κB pathway.
Tang ZH; Peng J; Ren Z; Yang J; Li TT; Li TH; Wang Z; Wei DH; Liu LS; Zheng XL; Jiang ZS
Atherosclerosis; 2017 Jul; 262():113-122. PubMed ID: 28535426
[TBL] [Abstract][Full Text] [Related]
14. Hepatic paraoxonase 1 ameliorates dysfunctional high-density lipoprotein and atherosclerosis in scavenger receptor class B type I deficient mice.
Zhao XJ; Liu LC; Guo C; Shen WW; Cao J; Du F; Wu DF; Yu H
Ann Transl Med; 2021 Jul; 9(13):1063. PubMed ID: 34422975
[TBL] [Abstract][Full Text] [Related]
15. Protective role for Toll-like receptor-9 in the development of atherosclerosis in apolipoprotein E-deficient mice.
Koulis C; Chen YC; Hausding C; Ahrens I; Kyaw TS; Tay C; Allen T; Jandeleit-Dahm K; Sweet MJ; Akira S; Bobik A; Peter K; Agrotis A
Arterioscler Thromb Vasc Biol; 2014 Mar; 34(3):516-25. PubMed ID: 24436372
[TBL] [Abstract][Full Text] [Related]
16. Rosuvastatin Reduces Aortic Sinus and Coronary Artery Atherosclerosis in SR-B1 (Scavenger Receptor Class B Type 1)/ApoE (Apolipoprotein E) Double Knockout Mice Independently of Plasma Cholesterol Lowering.
Yu P; Xiong T; Tenedero CB; Lebeau P; Ni R; MacDonald ME; Gross PL; Austin RC; Trigatti BL
Arterioscler Thromb Vasc Biol; 2018 Jan; 38(1):26-39. PubMed ID: 29162602
[TBL] [Abstract][Full Text] [Related]
17. The effects of miR-467b on lipoprotein lipase (LPL) expression, pro-inflammatory cytokine, lipid levels and atherosclerotic lesions in apolipoprotein E knockout mice.
Tian GP; Tang YY; He PP; Lv YC; Ouyang XP; Zhao GJ; Tang SL; Wu JF; Wang JL; Peng J; Zhang M; Li Y; Cayabyab FS; Zheng XL; Zhang DW; Yin WD; Tang CK
Biochem Biophys Res Commun; 2014 Jan; 443(2):428-34. PubMed ID: 24309104
[TBL] [Abstract][Full Text] [Related]
18. Macrophage-specific expression of human apolipoprotein E reduces atherosclerosis in hypercholesterolemic apolipoprotein E-null mice.
Bellosta S; Mahley RW; Sanan DA; Murata J; Newland DL; Taylor JM; Pitas RE
J Clin Invest; 1995 Nov; 96(5):2170-9. PubMed ID: 7593602
[TBL] [Abstract][Full Text] [Related]
19. Danhong injection inhibits the development of atherosclerosis in both Apoe⁻/⁻ and Ldlr⁻/⁻ mice.
Chen Y; Liu M; Zhao T; Zhao B; Jia L; Zhu Y; Zhang B; Gao X; Li G; Li X; Xiang R; Han J; Duan Y
J Cardiovasc Pharmacol; 2014 May; 63(5):441-52. PubMed ID: 24803317
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of apolipoprotein A-I-mimetic peptide on evolving and established atherosclerosis in apolipoprotein E-null mice.
Li X; Chyu KY; Faria Neto JR; Yano J; Nathwani N; Ferreira C; Dimayuga PC; Cercek B; Kaul S; Shah PK
Circulation; 2004 Sep; 110(12):1701-5. PubMed ID: 15353488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
